Bonded R&D, Bonded Production, Export Tax Refund 

1. Location

The International Biopharmaceutical Park Project (Phase One) in the Comprehensive Bonded Zone is located within the Beijing Daxing International Airport Economic Zone Comprehensive Bonded Zone, adjacent to the No 1 checkpoint of the Comprehensive Bonded Zone, approximately four kilometers from the Dianzi toll station on the Beijing-Taiwan Expressway, and about four kilometers from the under-construction S6 subway line Xinhangcheng Station.

The total land area of the project is approximately 200 acres, with a floor area of about 204,000 square meters, of which the first phase covers an area of approximately 80,000 square meters and a floor area of about 108,000 square meters.

2. Functional Positioning

The Comprehensive Bonded Zone is the first cross-provincial customs special supervision area in China serving the opening-up of the Beijing-Tianjin-Hebei region. The International Biopharmaceutical Park Project will leverage the advantages of Daxing Airport's international connectivity and the special policies of the Comprehensive Bonded Zone.

It is positioned as an incubator for the life medical industry, driving the overall development of the airport area with key industrial projects, enhancing the international exchange function of the Daxing Airport area, promoting regional open innovation, and achieving economic transformation and upgrading.

The project aims to create an international port for life and health in the air, integrating functions including bonded R&D, bonded production, focusing on attracting biopharmaceutical, medical device bonded R&D, and production enterprises, with production as the main focus and R&D as a supplement.

It also focuses on life and health CRO, CDMO enterprises, and construction of a public technology platform.

3. Project Highlights

The overall target is to create an "international port for life and health in the air, integrating functions such as bonded R&D, bonded production", focusing on the development and production of biopharmaceuticals, medical devices, and building a cluster of life and health industries.

4. Key Enterprises

Currently, the park has attracted several professional biopharmaceutical companies, including Beijing KALS Medical Devices Co, Ltd (the market leader in domestic dental implants), Beijing Yisheng Biotechnology Co, Ltd (a leading enterprise in islet stem cell industry), and Beijing Yuma Biotechnology Co, Ltd (the only internationally standardized large animal laboratory in China).